Developer docs
API playgroundTry for free, no card

Search company profiles

LIS Technologies

Full company profile

uuid0000clz

Namestring
LIS Technologies
Legal namestring
LIS Technologies Inc.
Websiteurl
laseristech.com
Company typeenum
Private
Founded yearint
2021
Descriptiontext

LIS Technologies Inc. (LIST) is a U.S.-based, privately held nuclear technology company developing the patented CRISLA (Condensation Repression Isotope Selective Laser Activation) process — the only U.S.-origin and patented laser uranium enrichment technology. The company's current-generation CRISLA-3G variant uses infrared lasers at 5.3µm to selectively excite the 3ν3 vibrational mode of 235UF6 molecules, separating them from other isotopes; this approach was independently evaluated at TRL-4 (with 60% of TRL-5 elements met) per DOE guide DOE G 413.3-4A and is positioned to address both LEU production for the existing 94-reactor U.S. civilian fleet and HALEU production for next-generation SMRs and microreactors. LIST's primary revenue streams today are pre-commercial: a prime contractor slot on the U.S. DOE's $3.4 billion / 10-year Low-Enriched Uranium Enrichment Acquisition Program IDIQ (one of six domestic awardees, December 2024), an AFWERX SBIR Phase I feasibility contract (March 2025), and other government/defense research work; commercial LEU and HALEU sales from the planned $1.38 billion LEU-3 facility on LIST Island (206 acres at the historic K-25 site in Oak Ridge, TN) are targeted before 2030. The company also operates the Stable and Medical Isotope Laser Enrichment Program (Project SMILE), extending CRISLA into non-uranium markets such as silicon-28 for advanced semiconductors and quantum computing, and medical isotopes. LIST is led by Executive Chairman & CEO Jay Yu (also founder of NASDAQ-listed NANO Nuclear Energy), President & Co-Founder Christo Liebenberg, and Co-Founder & CTO Dr. Jeff W. Eerkens — the original patent-holder known as the "father of laser enrichment" — alongside senior advisors including former NNSA Deputy Administrator Brent Park, retired Lt. Gen. Hinote (USAF), retired Gen. Paxton (USMC), and former Congressman Shimkus.

Short descriptiontext

LIS Technologies Inc. is a U.S.-based, privately held nuclear-technology company developing the patented CRISLA laser process — the only U.S.-origin patented laser uranium enrichment technology — to produce LEU for the existing 94-reactor U.S. civilian fleet and HALEU for next-generation SMRs and microreactors, serving the DOE, U.S. Air Force, and future utility customers.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersNew York, United States
HQ citystring
New York
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
laser uranium enrichment, isotope separation technology, nuclear fuel enrichment, HALEU production, stable isotope enrichment
Industry1 code
PRIMARYEUAKACAD
Uranium Enrichment Services (Centrifuge/Laser, SWU Supply)
Energy, Utilities & Environment/Nuclear Energy/Nuclear Fuel Cycle (Mining, Conversion, Enrichment & Fuel Fabrication)
NAICS code1 code
  • Irradiation Apparatus Manufacturing334517
SIC code1 code
  • X-Ray Apparatus & Tubes & Related Irradiation Apparatus3844
Product category
Nuclear Fuel Enrichment
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model4 records
1Government Contract Revenue (DOE IDIQ)
TypeManaged Services
Description

Prime contractor on the U.S. Department of Energy's Low-Enriched Uranium (LEU) Enrichment Acquisition Program — a 10-year IDIQ contract worth up to $3.4 billion across six awardees, with a minimum task order value of $2 million. Revenue is task-order based and depends on DOE-issued bids.

laseristech.com
2Defense/Government Research Contracts
TypeProfessional Services
Description

SBIR Phase I contract awarded by AFWERX (U.S. Air Force) for feasibility study on enriching uranium to support Department of the Air Force global operations. Additional NRC Facility Clearance enables access to classified matter and further defense contracting opportunities.

marketsherald.com
3Future Uranium Enrichment Sales (LEU and HALEU)
TypeTransaction Fee
Description

Planned commercial sales of Low-Enriched Uranium (LEU) and High-Assay Low-Enriched Uranium (HALEU) from the planned LEU-3 commercial facility on LIST Island in Oak Ridge, TN, with a target annual capacity of up to 5.5 million Separative Work Units (SWU). Commercial operations targeted before 2030.

nationaltoday.com
4Stable and Medical Isotope Sales (Future)
TypeTransaction Fee
Description

Future revenue from enriched stable isotopes (e.g., silicon-28 for advanced semiconductor/AI chips and quantum computing) and medical isotopes, sold via the Stable and Medical Isotope Laser Enrichment Program (Project SMILE). Accepts custom isotope product requests via website form.

laseristech.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Technology or R&D, Personnel, Infrastructure, Operations, Marketing or Sales, Supply Chain
Pricing details1 tier
1Not publicly disclosed for products/services
ModelOther
Notes

Quote-based / not publicly disclosed for uranium enrichment and isotope products.

laseristech.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

LIS Technologies develops and commercializes CRISLA (Condensation Repression Isotope Selective Laser Activation), a U.S.-origin patented laser uranium enrichment technology that uses 5.3μm infrared CO2 lasers to selectively excite 235UF6 molecules for separation. The technology produces Low-Enriched Uranium (LEU) for the existing 94-reactor U.S. fleet and High-Assay Low-Enriched Uranium (HALEU) for next-generation small modular and microreactors, and is being extended via Project SMILE into stable isotopes (e.g., silicon-28) and medical isotopes. Commercial production is being built out at the LEU-3 facility on LIST Island in Oak Ridge, Tennessee, with a target capacity of up to 5.5 million Separative Work Units (SWU) annually.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • Target annual production of up to 5.5 million Separative Work Units (SWU) of enriched uranium
+5 more records
Product overview1 text field

LIS Technologies Inc. operates a single core patented technology platform — CRISLA (Condensation Repression Isotope Selective Laser Activation) and its third-generation variant CRISLA-3G — applied across a portfolio of physical/nuclear products and programs. The core laser uranium enrichment technology powers the flagship commercial LEU-3 Enrichment Facility under the Project F.U.E.L. (Future Uranium Enrichment with Lasers) initiative being built on LIST Island in Oak Ridge, Tennessee. R&D activities for the platform run through the licensed Test Demonstration Facility at the K-1330 building on the historic K-25 site, while a parallel adjacent program, Project SMILE (Stable and Medical Isotope Laser Enrichment Program), extends the same CRISLA technology into stable and medical isotope enrichment for advanced electronics, quantum computing, and healthcare applications.

Product and service5 records
1CRISLA Laser Uranium Enrichment Technology
CategoryCore Technology / IP Platform
Description

The only U.S.-origin, USPTO-patented laser uranium enrichment technology, using infrared lasers to selectively excite 235UF6 molecules at the 3ν3 vibrational mode for isotope separation. Conceptualized and patented by Dr. Jeff Eerkens ("the father of laser enrichment") and experimentally demonstrated at LEU levels in the 1980s and 1990s, it serves as the foundational technology platform for all of LIST's uranium and isotope enrichment products.

2CRISLA-3G
CategoryTechnology Variant / Productized Generation
Description

Third-generation CRISLA laser isotope separation technology featuring a proprietary 5.3μm CO2 laser architecture with high throughput, high duty cycle, and reduced complexity. Designed to demonstrate LEU production in a single stage and HALEU production in two stages with fully scaled and industrialized equipment.

3Low-Enriched Uranium (LEU)
CategoryNuclear Fuel Product
Description

Low-Enriched Uranium (LEU) fuel product for the existing 94-reactor U.S. commercial nuclear fleet. Produced via CRISLA-3G technology with a single-stage enrichment process; planned commercial output of up to 5.5 million Separative Work Units (SWU) annually from the LEU-3 facility on LIST Island.

4High-Assay Low-Enriched Uranium (HALEU)
CategoryNuclear Fuel Product
Description

High-Assay Low-Enriched Uranium (HALEU) fuel product for next-generation Small Modular Reactors (SMRs) and microreactors. Produced via a two-stage CRISLA-3G enrichment process at the LEU-3 commercial facility planned for LIST Island, Oak Ridge, TN.

5Project SMILE Stable and Medical Isotopes
CategoryStable and Medical Isotope Products
Description

Enriched stable isotopes (including silicon-28 for advanced semiconductors and quantum computing) and medical isotopes for detection, treatment, and theranostic applications, produced via the same CRISLA laser excitation principle applied to non-uranium elements. Customers can request custom isotope products via an online form on laseristech.com.

Scale indicator11 records

Each record includes

Type, Value, Description, Source

Partnership9 partners
1State of Tennessee / Tennessee Department of Economic and Community Development
Strategic tierCoreTypeOthersAnnounced on2026-01-16
Description

Tennessee Governor Bill Lee and Deputy Governor / Department of Economic and Community Development Commissioner Stuart C. McWhorter jointly announced LIS Technologies' $1.38 billion investment in Oak Ridge alongside company leadership. State support enabled the 206-acre LIST Island acquisition, regulatory licensing (Radioactive Material License), and workforce development for 203 jobs.

wvlt.tv
Strategic tierFlagshipTypeImplementation/ SI/ Consulting PartnerAnnounced on2025-11-04
Description

Enveniam signed an agreement with LIS Technologies Inc. to serve as Lead Project Integrator for the development of the laser-based uranium enrichment facility (Project F.U.E.L. / LEU-3 facility) on LIST Island in Oak Ridge, Tennessee. Enveniam will lead engineering, procurement, and construction coordination for the $1.38 billion facility investment on the 206-acre K-25 site.

Strategic tierMinorTypeGTM or Marketing PartnerAnnounced on2025-03-20
Description

LIS Technologies sponsored the 4th Annual Energy & Elements Gala at the American Museum of Science and Energy in Oak Ridge, Tennessee (March 20, 2026) and has been a recurring sponsor of museum and community events to support STEM and nuclear education.

Strategic tierCoreTypeOthersAnnounced on2025-03-07
Description

LIS Technologies ("LIST") was selected by AFWERX for a SBIR Phase I contract focused on enhancing its Condensation Repression Isotope Selective Laser Activation (CRISLA) technology. Contract covers a feasibility study on enriching uranium to empower Department of the Air Force's global operations.

Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2024-12-01
Description

NANO Nuclear Energy is a key subcontractor and strategic partner of LIS Technologies under the DOE Low-Enriched Uranium Enrichment Acquisition Program IDIQ contract (Dec 2024). NANO brings technical and regulatory expertise in advanced nuclear solutions including fuel deconversion, fuel fabrication, and fuel transportation. The companies share certain common ownership and commonality of officers and directors (Jay Yu is founder of both). Collaboration goal: vertically integrated fuel pipeline for LEU and HALEU production.

Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2024-12-01
Description

LIS Technologies is a prime contractor (with NANO Nuclear Energy as subcontractor) on the DOE's Low-Enriched Uranium (LEU) Enrichment Acquisition Program — a $3.4 billion / 10-year IDIQ contract with a minimum $2 million task order value. DOE issues task orders that LIST bids on to support domestic fuel supply chain development for current 94 reactors and future advanced reactors.

Strategic tierMinorTypeOthersAnnounced on2024-12-01
Description

LIS Technologies joined the Nuclear Energy Institute (NEI) on March 7, 2025 — a leading policy organization in support of the nuclear energy industry in the United States and abroad. Membership supports policy advocacy and industry collaboration.

Strategic tierMinorTypeOthersAnnounced on2024-09-01
Description

LIS Technologies became a member of the American Nuclear Society (ANS), the premier nuclear science organization. The company also sponsored the 2025 ANS Winter Conference & Expo in Washington D.C. (Nov 8-12, 2025) at the Elite Level.

9World Nuclear Association & Nuclear Institute
Strategic tierMinorTypeOthersAnnounced on2024-03-01
Description

LIS Technologies officially joined the World Nuclear Association (WNA), a global advocate for the nuclear industry, and established corporate affiliation with the Nuclear Institute. The company also sponsors the World Nuclear Symposium 2024 and World Nuclear Fuel Cycle 2025/2026 events.

laseristech.com
Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

U.S.-based uranium enricher operating HALEU production at the Piketon, Ohio site with NRC-licensed centrifuge capacity. Directly competes with LIS Technologies for DOE LEU/HALEU task orders under the same IDIQ program and the same 94-reactor fleet customers.

TypeDirect peer
Description

Wholly owned by CAMECO and GE Hitachi, GLE holds the SILEX laser enrichment license and operates a test loop at the Paducah, Kentucky site. Pursues commercial-scale laser enrichment using a competing (third-party-origin) laser method, directly overlapping with LIST's domestic laser enrichment thesis.

TypeEmerging player
Description

U.S. laser uranium enrichment startup that raised a substantial 2024 private round and is explicitly listed alongside LIS Technologies as a beneficiary of domestic enrichment investment. Competes for the same DOE funding and advanced-reactor fuel customers.

TypeBroad incumbent
Description

Foreign (UK/Germany/Netherlands) centrifuge uranium enrichment incumbent supplying a large share of Western LEU. Provides the incumbent benchmark against which LIST and other U.S. domestic producers are positioning for reshored supply.

5Orano
TypeBroad incumbent
Description

French state-owned uranium enricher (formerly Areva) operating the Georges Besse II centrifuge plant. Major non-Russian, non-U.S. foreign enricher whose customers LIST could displace in U.S. utility procurement.

TypeDirect peer
Description

NASDAQ-listed (NNE) advanced nuclear micro-reactor and fuel transportation company that is LIST's key subcontractor on the DOE IDIQ and shares executive overlap (Jay Yu, Christo Liebenberg). Competes in adjacent fuel-cycle services (HALEU transport, fuel fabrication, deconversion) and serves as LIST's strategic vertical-integration partner.

TypeBroad incumbent
Description

U.S. nuclear components, fuel, and naval propulsion specialist. Operates NRC-licensed nuclear fuel fabrication and is a potential competitor/customer for HALEU supply to U.S. Navy propulsion reactors, a use case LIST is also pursuing.

TypeEmerging player
Description

U.S. fusion-and-medical-isotope company producing medical isotopes using accelerator and fusion-based technologies. Direct competitor to LIST's Project SMILE medical isotope program.

TypeEmerging player
Description

U.S. advanced nuclear fuel developer designing next-generation metallic fuel rods for SMRs and large reactors. Adjacent peer in the HALEU-fuel value chain that LIST would supply as an upstream enricher.

TypeEmerging player
Description

U.S. medical and stable isotope producer competing for the same therapeutic and diagnostic isotope end-markets LIST targets through Project SMILE, using non-laser production methods.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles12 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance8 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds6 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors3 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

LIS Technologies

Nuclear Fuel Enrichmentlaseristech.com

LIS Technologies Inc. is a U.S.-based, privately held nuclear-technology company developing the patented CRISLA laser process — the only U.S.-origin patented laser uranium enrichment technology — to produce LEU for the existing 94-reactor U.S. civilian fleet and HALEU for next-generation SMRs and microreactors, serving the DOE, U.S. Air Force, and future utility customers.

What LIS Technologies does

LIS Technologies Inc. (LIST) is a U.S.-based, privately held nuclear technology company developing the patented CRISLA (Condensation Repression Isotope Selective Laser Activation) process — the only U.S.-origin and patented laser uranium enrichment technology. The company's current-generation CRISLA-3G variant uses infrared lasers at 5.3µm to selectively excite the 3ν3 vibrational mode of 235UF6 molecules, separating them from other isotopes; this approach was independently evaluated at TRL-4 (with 60% of TRL-5 elements met) per DOE guide DOE G 413.3-4A and is positioned to address both LEU production for the existing 94-reactor U.S. civilian fleet and HALEU production for next-generation SMRs and microreactors. LIST's primary revenue streams today are pre-commercial: a prime contractor slot on the U.S. DOE's $3.4 billion / 10-year Low-Enriched Uranium Enrichment Acquisition Program IDIQ (one of six domestic awardees, December 2024), an AFWERX SBIR Phase I feasibility contract (March 2025), and other government/defense research work; commercial LEU and HALEU sales from the planned $1.38 billion LEU-3 facility on LIST Island (206 acres at the historic K-25 site in Oak Ridge, TN) are targeted before 2030. The company also operates the Stable and Medical Isotope Laser Enrichment Program (Project SMILE), extending CRISLA into non-uranium markets such as silicon-28 for advanced semiconductors and quantum computing, and medical isotopes. LIST is led by Executive Chairman & CEO Jay Yu (also founder of NASDAQ-listed NANO Nuclear Energy), President & Co-Founder Christo Liebenberg, and Co-Founder & CTO Dr. Jeff W. Eerkens — the original patent-holder known as the "father of laser enrichment" — alongside senior advisors including former NNSA Deputy Administrator Brent Park, retired Lt. Gen. Hinote (USAF), retired Gen. Paxton (USMC), and former Congressman Shimkus.

LIS Technologies firmographics

Firmographics
Name
LIS Technologies
Legal name
LIS Technologies Inc.
Website
https://laseristech.com
Company type
Private
Founded year
2021
Operating status
Operating
Headcount range
11–50 employees
Short description
LIS Technologies Inc. is a U.S.-based, privately held nuclear-technology company developing the patented CRISLA laser process — the only U.S.-origin patented laser uranium enrichment technology — to produce LEU for the existing 94-reactor U.S. civilian fleet and HALEU for next-generation SMRs and microreactors, serving the DOE, U.S. Air Force, and future utility customers.
Ownership category
akta.pro rank

LIS Technologies industry classification

Industry
Product category
Nuclear Fuel Enrichment
NAICS
Irradiation Apparatus Manufacturing (334517)
SIC
X-Ray Apparatus & Tubes & Related Irradiation Apparatus (3844)
akta.pro industry
PRIMARYEUAKACAD
Uranium Enrichment Services (Centrifuge/Laser, SWU Supply)
Energy, Utilities & Environment/Nuclear Energy/Nuclear Fuel Cycle (Mining, Conversion, Enrichment & Fuel Fabrication)

Keywords

  • Laser uranium enrichment
  • Isotope separation technology
  • Nuclear fuel enrichment
  • HALEU production
  • Stable isotope enrichment

Where LIS Technologies is headquartered

Location

Headquarters

HQ city
New York
HQ country
United States
HQ region
North America

Offices3 records

Markets served

LIS Technologies business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel, Infrastructure, Operations, Marketing or Sales, Supply Chain

Revenue model

  1. Government Contract Revenue (DOE IDIQ): Prime contractor on the U.S. Department of Energy's Low-Enriched Uranium (LEU) Enrichment Acquisition Program — a 10-year IDIQ contract worth up to $3.4 billion across six awardees, with a minimum task order value of $2 million. Revenue is task-order based and depends on DOE-issued bids.
  2. Defense/Government Research Contracts: SBIR Phase I contract awarded by AFWERX (U.S. Air Force) for feasibility study on enriching uranium to support Department of the Air Force global operations. Additional NRC Facility Clearance enables access to classified matter and further defense contracting opportunities.
  3. Future Uranium Enrichment Sales (LEU and HALEU): Planned commercial sales of Low-Enriched Uranium (LEU) and High-Assay Low-Enriched Uranium (HALEU) from the planned LEU-3 commercial facility on LIST Island in Oak Ridge, TN, with a target annual capacity of up to 5.5 million Separative Work Units (SWU). Commercial operations targeted before 2030.
  4. Stable and Medical Isotope Sales (Future): Future revenue from enriched stable isotopes (e.g., silicon-28 for advanced semiconductor/AI chips and quantum computing) and medical isotopes, sold via the Stable and Medical Isotope Laser Enrichment Program (Project SMILE). Accepts custom isotope product requests via website form.

Pricing tiers

ModelBillingPrice
Other—Not publicly disclosed for products/services

Go-to-market motion1 record

Distribution channels5 records

Marketing channels7 records

LIS Technologies product offering

Product offering

Core offering

LIS Technologies develops and commercializes CRISLA (Condensation Repression Isotope Selective Laser Activation), a U.S.-origin patented laser uranium enrichment technology that uses 5.3μm infrared CO2 lasers to selectively excite 235UF6 molecules for separation. The technology produces Low-Enriched Uranium (LEU) for the existing 94-reactor U.S. fleet and High-Assay Low-Enriched Uranium (HALEU) for next-generation small modular and microreactors, and is being extended via Project SMILE into stable isotopes (e.g., silicon-28) and medical isotopes. Commercial production is being built out at the LEU-3 facility on LIST Island in Oak Ridge, Tennessee, with a target capacity of up to 5.5 million Separative Work Units (SWU) annually.

Product overview

LIS Technologies Inc. operates a single core patented technology platform — CRISLA (Condensation Repression Isotope Selective Laser Activation) and its third-generation variant CRISLA-3G — applied across a portfolio of physical/nuclear products and programs. The core laser uranium enrichment technology powers the flagship commercial LEU-3 Enrichment Facility under the Project F.U.E.L. (Future Uranium Enrichment with Lasers) initiative being built on LIST Island in Oak Ridge, Tennessee. R&D activities for the platform run through the licensed Test Demonstration Facility at the K-1330 building on the historic K-25 site, while a parallel adjacent program, Project SMILE (Stable and Medical Isotope Laser Enrichment Program), extends the same CRISLA technology into stable and medical isotope enrichment for advanced electronics, quantum computing, and healthcare applications.

Differentiator

Problem solved

Functional benefit

Products and services

  • CRISLA Laser Uranium Enrichment Technology The only U.S.-origin, USPTO-patented laser uranium enrichment technology, using infrared lasers to selectively excite 235UF6 molecules at the 3ν3 vibrational mode for isotope separation. Conceptualized and patented by Dr. Jeff Eerkens ("the father of laser enrichment") and experimentally demonstrated at LEU levels in the 1980s and 1990s, it serves as the foundational technology platform for all of LIST's uranium and isotope enrichment products.
  • CRISLA-3G Third-generation CRISLA laser isotope separation technology featuring a proprietary 5.3μm CO2 laser architecture with high throughput, high duty cycle, and reduced complexity. Designed to demonstrate LEU production in a single stage and HALEU production in two stages with fully scaled and industrialized equipment.
  • Low-Enriched Uranium (LEU) Low-Enriched Uranium (LEU) fuel product for the existing 94-reactor U.S. commercial nuclear fleet. Produced via CRISLA-3G technology with a single-stage enrichment process; planned commercial output of up to 5.5 million Separative Work Units (SWU) annually from the LEU-3 facility on LIST Island.
  • High-Assay Low-Enriched Uranium (HALEU) High-Assay Low-Enriched Uranium (HALEU) fuel product for next-generation Small Modular Reactors (SMRs) and microreactors. Produced via a two-stage CRISLA-3G enrichment process at the LEU-3 commercial facility planned for LIST Island, Oak Ridge, TN.
  • Project SMILE Stable and Medical Isotopes Enriched stable isotopes (including silicon-28 for advanced semiconductors and quantum computing) and medical isotopes for detection, treatment, and theranostic applications, produced via the same CRISLA laser excitation principle applied to non-uranium elements. Customers can request custom isotope products via an online form on laseristech.com.

Quantifiable outcome

  • Target annual production of up to 5.5 million Separative Work Units (SWU) of enriched uranium
  • +5 more outcomes

Companies that use LIS Technologies

Customer profile

Named customers3 records

Ideal customer profiles4 records

LIS Technologies technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

LIS Technologies partnerships and signals

Strategic signal

Partnerships

Nine partnerships are on record, tiered core, flagship and minor.

  • State of Tennessee / Tennessee Department of Economic and Community DevelopmentcoreOthers · 16 January 2026Tennessee Governor Bill Lee and Deputy Governor / Department of Economic and Community Development Commissioner Stuart C. McWhorter jointly announced LIS Technologies' $1.38 billion investment in Oak Ridge alongside company leadership. State support enabled the 206-acre LIST Island acquisition, regulatory licensing (Radioactive Material License), and workforce development for 203 jobs.
  • Enveniam, LLC (a Bernhard Capital Partners platform)flagshipImplementation/ SI/ Consulting Partner · 4 November 2025Enveniam signed an agreement with LIS Technologies Inc. to serve as Lead Project Integrator for the development of the laser-based uranium enrichment facility (Project F.U.E.L. / LEU-3 facility) on LIST Island in Oak Ridge, Tennessee. Enveniam will lead engineering, procurement, and construction coordination for the $1.38 billion facility investment on the 206-acre K-25 site.
  • American Museum of Science and Energy FoundationminorGTM or Marketing Partner · 20 March 2025LIS Technologies sponsored the 4th Annual Energy & Elements Gala at the American Museum of Science and Energy in Oak Ridge, Tennessee (March 20, 2026) and has been a recurring sponsor of museum and community events to support STEM and nuclear education.
  • AFWERX (U.S. Air Force)coreOthers · 7 March 2025LIS Technologies ("LIST") was selected by AFWERX for a SBIR Phase I contract focused on enhancing its Condensation Repression Isotope Selective Laser Activation (CRISLA) technology. Contract covers a feasibility study on enriching uranium to empower Department of the Air Force's global operations.
  • NANO Nuclear Energy Inc. (NASDAQ: NNE)flagshipStrategic or Co-development Partner · 1 December 2024NANO Nuclear Energy is a key subcontractor and strategic partner of LIS Technologies under the DOE Low-Enriched Uranium Enrichment Acquisition Program IDIQ contract (Dec 2024). NANO brings technical and regulatory expertise in advanced nuclear solutions including fuel deconversion, fuel fabrication, and fuel transportation. The companies share certain common ownership and commonality of officers and directors (Jay Yu is founder of both). Collaboration goal: vertically integrated fuel pipeline for LEU and HALEU production.
  • U.S. Department of Energy (DOE)flagshipStrategic or Co-development Partner · 1 December 2024LIS Technologies is a prime contractor (with NANO Nuclear Energy as subcontractor) on the DOE's Low-Enriched Uranium (LEU) Enrichment Acquisition Program — a $3.4 billion / 10-year IDIQ contract with a minimum $2 million task order value. DOE issues task orders that LIST bids on to support domestic fuel supply chain development for current 94 reactors and future advanced reactors.
  • Nuclear Energy Institute (NEI)minorOthers · 1 December 2024LIS Technologies joined the Nuclear Energy Institute (NEI) on March 7, 2025 — a leading policy organization in support of the nuclear energy industry in the United States and abroad. Membership supports policy advocacy and industry collaboration.
  • American Nuclear Society (ANS)minorOthers · 1 September 2024LIS Technologies became a member of the American Nuclear Society (ANS), the premier nuclear science organization. The company also sponsored the 2025 ANS Winter Conference & Expo in Washington D.C. (Nov 8-12, 2025) at the Elite Level.
  • World Nuclear Association & Nuclear InstituteminorOthers · 1 March 2024LIS Technologies officially joined the World Nuclear Association (WNA), a global advocate for the nuclear industry, and established corporate affiliation with the Nuclear Institute. The company also sponsors the World Nuclear Symposium 2024 and World Nuclear Fuel Cycle 2025/2026 events.

Scale indicators11 records

Recent moves8 records

Expansion highlights6 records

LIS Technologies competitors and assessment

Company assessment

Direct peers

  • Centrus Energy: U.S.-based uranium enricher operating HALEU production at the Piketon, Ohio site with NRC-licensed centrifuge capacity. Directly competes with LIS Technologies for DOE LEU/HALEU task orders under the same IDIQ program and the same 94-reactor fleet customers.
  • Global Laser Enrichment: Wholly owned by CAMECO and GE Hitachi, GLE holds the SILEX laser enrichment license and operates a test loop at the Paducah, Kentucky site. Pursues commercial-scale laser enrichment using a competing (third-party-origin) laser method, directly overlapping with LIST's domestic laser enrichment thesis.
  • NANO Nuclear Energy: NASDAQ-listed (NNE) advanced nuclear micro-reactor and fuel transportation company that is LIST's key subcontractor on the DOE IDIQ and shares executive overlap (Jay Yu, Christo Liebenberg). Competes in adjacent fuel-cycle services (HALEU transport, fuel fabrication, deconversion) and serves as LIST's strategic vertical-integration partner.

Emerging players

  • General Matter: U.S. laser uranium enrichment startup that raised a substantial 2024 private round and is explicitly listed alongside LIS Technologies as a beneficiary of domestic enrichment investment. Competes for the same DOE funding and advanced-reactor fuel customers.
  • Shine Technologies: U.S. fusion-and-medical-isotope company producing medical isotopes using accelerator and fusion-based technologies. Direct competitor to LIST's Project SMILE medical isotope program.
  • Lightbridge Corporation: U.S. advanced nuclear fuel developer designing next-generation metallic fuel rods for SMRs and large reactors. Adjacent peer in the HALEU-fuel value chain that LIST would supply as an upstream enricher.
  • NorthStar Medical Radioisotopes: U.S. medical and stable isotope producer competing for the same therapeutic and diagnostic isotope end-markets LIST targets through Project SMILE, using non-laser production methods.

Broad incumbents

  • Urenco: Foreign (UK/Germany/Netherlands) centrifuge uranium enrichment incumbent supplying a large share of Western LEU. Provides the incumbent benchmark against which LIST and other U.S. domestic producers are positioning for reshored supply.
  • Orano: French state-owned uranium enricher (formerly Areva) operating the Georges Besse II centrifuge plant. Major non-Russian, non-U.S. foreign enricher whose customers LIST could displace in U.S. utility procurement.
  • BWX Technologies: U.S. nuclear components, fuel, and naval propulsion specialist. Operates NRC-licensed nuclear fuel fabrication and is a potential competitor/customer for HALEU supply to U.S. Navy propulsion reactors, a use case LIST is also pursuing.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

LIS Technologies social profiles

Digital presence

LIS Technologies compliance and trust

Trust signal

Compliance8 records

LIS Technologies financial estimates

Financial estimate

Revenue estimate

Valuation estimate

LIS Technologies leadership team

Management profile

Number of profiles

Profiles12 records

LIS Technologies subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

LIS Technologies funding detail

Funding detail

Funding overview

Funding rounds6 records

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

LIS Technologies M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about LIS Technologies

What does LIS Technologies do?

LIS Technologies develops and commercializes CRISLA (Condensation Repression Isotope Selective Laser Activation), a U.S.-origin patented laser uranium enrichment technology that uses 5.3μm infrared CO2 lasers to selectively excite 235UF6 molecules for separation. The technology produces Low-Enriched Uranium (LEU) for the existing 94-reactor U.S. fleet and High-Assay Low-Enriched Uranium (HALEU) for next-generation small modular and microreactors, and is being extended via Project SMILE into stable isotopes (e.g., silicon-28) and medical isotopes. Commercial production is being built out at the LEU-3 facility on LIST Island in Oak Ridge, Tennessee, with a target capacity of up to 5.5 million Separative Work Units (SWU) annually.

Is LIS Technologies a public or private company?

LIS Technologies is a private company. It is classified as venture growth investor backed and is currently operating.

When was LIS Technologies founded?

LIS Technologies was founded in 2021. It employs 11 to 50 people.

Where is LIS Technologies based?

LIS Technologies is headquartered in New York, United States, in the North America region.

How does LIS Technologies make money?

Four revenue lines are on record. Government Contract Revenue (DOE IDIQ) is the primary driver. The others are defense/Government Research Contracts, future Uranium Enrichment Sales (LEU and HALEU) and stable and Medical Isotope Sales (Future).

Who are LIS Technologies's main competitors?

Direct peers on record are Centrus Energy, Global Laser Enrichment and NANO Nuclear Energy. Emerging players are General Matter, Shine Technologies, Lightbridge Corporation and NorthStar Medical Radioisotopes. Broad incumbents are Urenco, Orano and BWX Technologies.

Does LIS Technologies have an API?

No public API is recorded for LIS Technologies.

What industry is LIS Technologies in?

LIS Technologies's product category is Nuclear Fuel Enrichment. Its primary akta.pro industry code is EUAKACAD, Uranium Enrichment Services (Centrifuge/Laser, SWU Supply). Its NAICS code is 334517 and its SIC code is 3844.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
NewsfileLIS Technologies Inc. Announces Major Milestone with the Receipt of an Initial Shipment of Uranium Hexafluoride (UF6) to be Leveraged at its State-of-the-Art Demonstration Test Loop FacilityLIS Technologies accepted its first shipment of uranium hexafluoride (UF6) for testing at its Oak Ridge demonstration facility. The shipment enables optimization of its CRISLA-4G laser enrichment process, aiming for Technology Readiness Level 5. The company plans to use this to advance its commercial laser-based enrichment facilities.AktienLIS Technologies Inc. Announces Major Milestone with the Receipt of an Initial Shipment of Uranium Hexafluoride (UF6) to be Leveraged at its State-of-the-Art Demonstration Test Loop FacilityLIS Technologies accepted its first shipment of uranium hexafluoride (UF6) for testing its CRISLA-4G laser enrichment process at its Oak Ridge, Tennessee facility. The shipment enables proof-of-concept testing, process optimization, and integrated loop testing. The company, a U.S.-origin developer of patented laser enrichment technology, received a radioactive material license in late 2025.Nuclear Engineering InternationalLIST takes first steps toward FUELLIS Technologies began site preparation at its Oak Ridge facility for Project FUEL, a laser-based uranium enrichment plant. The company is investing $1.38bn in the LEU-3 Facility, targeting 5.5m SWU capacity and commercial operations by the early 2030s. LIST also acquired a K-25 support building for isotope production.Nuclear Engineering InternationalLIST acquires Oak Ridge isotope facilityLIST Technologies acquired the renovated K-1580 facility at Oak Ridge's K-25 site for $6.2 million. The 37,800-square-foot building will host medical and stable isotope production, complementing its existing K-1330 test facility. The company plans to break ground on a commercial-scale laser enrichment plant later this year, targeting operations before 2030.GlobeNewswireLIS Technologies Inc. Announces Opening Keynote Presentation and Platinum Sponsorship of Reuters Events’ SMR and Advanced Reactor 2026 ConferenceLIS Technologies announced its platinum sponsorship of Reuters Events' SMR and Advanced Reactor 2026 conference in Austin, Texas, on May 11-12, 2026. President Christo Liebenberg will deliver the Day 1 keynote on laser uranium enrichment. The company also highlighted its Phase 2 pilot plant demonstration as a prerequisite for commercial facility economics.NewsfileLIS Technologies Inc. Announces Opening Keynote Presentation and Platinum Sponsorship of Reuters Events' SMR and Advanced Reactor 2026 ConferenceLIS Technologies announced its platinum sponsorship of Reuters Events' SMR and Advanced Reactor 2026 conference in Austin, Texas, on May 11-12, 2026. President Christo Liebenberg will deliver the Day 1 keynote on laser uranium enrichment. The company also highlighted its participation in the Low-Enriched Uranium Enrichment Acquisition Program.GlobeNewswireLIS Technologies Inc., Developer of the Only U.S. Origin and Patented Technology for Laser Uranium Enrichment, Announces its Platinum Sponsorship and Executives’ Participation in the World Nuclear FueLIS Technologies announced its platinum sponsorship of the World Nuclear Fuel Cycle 2026 conference in Monaco, with executives leading sessions and a special event. The company highlighted nuclear power's role amid fuel constraints from geopolitical tensions. The event runs April 14-16, 2026.Seeking AlphaThe Future Of Uranium Enrichment Is Being Developed TodayUranium enrichment has been identified as a domestic vulnerability for the United States, with traditional gas-centrifuge technology serving the current reactor fleet. Next-generation laser-based enrichment methods are being developed by companies including Silex Systems, ASP Isotopes, and LIS Technologies, promising higher efficiency, lower energy use, smaller facilities, and faster deployment compared to conventional centrifuge technology. The VettaFi Nuclear Renaissance Index (NUKZX) tracks companies adding new enrichment capacity, with Centrus Energy Corp. advancing its centrifuge-based operations and a $900 million DOE contract enabling commercial-scale HALEU and LEU production.National TodayLIS Technologies Raises $7.1M in Oversubscribed Funding for Laser Uranium EnrichmentLIS Technologies Inc. has closed a $7.128 million oversubscribed funding round, its fifth consecutive, to advance its patented laser uranium enrichment technology. The capital will support Project F.U.E.L. and construction of the LIST Island facility at the historic K-25 Site in Oak Ridge, Tennessee, aiming to produce up to 5.5 million Separative Work Units annually. The company expects to begin construction plans for its commercial LEU-3 Enrichment Facility in 2026, with completion targeted for the early 2030s.Defence-blogExpert links private nuclear sector to U.S. defense resiliencePrivate-sector nuclear firms are increasingly entering the uranium enrichment field, traditionally dominated by government programs, as the United States seeks to rebuild domestic nuclear fuel supply capacity amid strategic competition with Russia and China. Christo Liebenberg, co-founder of uranium enrichment company LIS Technologies, argues that domestic enrichment capability is directly tied to national security, naval propulsion, and defense energy resilience. Companies like LIS Technologies are working to restore domestic enrichment capacity and accelerate innovation in advanced reactor fuels such as HALEU and small modular reactors that could support secure military installations.